Holen Sie sich die Stockscreener-App
74.38
2.32%
-1.77
Vorhandelsmarkt:
74.40
0.02
+0.03%
Schlusskurs vom Vortag:
$76.15
Offen:
$76.15
24-Stunden-Volumen:
310.56K
Relative Volume:
0.56
Marktkapitalisierung:
$2.84B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-241.60M
KGV:
-11.24
EPS:
-6.6167
Netto-Cashflow:
$-201.34M
1W Leistung:
-2.11%
1M Leistung:
+5.07%
6M Leistung:
+0.51%
1J Leistung:
+28.75%
1-Tages-Spanne:
$74.19
$77.48
1-Wochen-Bereich:
$72.21
$77.48
52-Wochen-Spanne:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
74.38 | 2.84B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
480.50 | 121.95B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.15 | 70.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.19 | 52.94B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
180.39 | 38.35B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
272.67 | 36.40B | 4.29B | 577.22M | 641.34M | 4.2086 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Fortgesetzt | Stifel | Buy |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
(IRON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Truist Securities Initiates Coverage of Disc Medicine (IRON) with Buy Recommendation - MSN
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
Lobbying Update: $50,000 of DISC MEDICINE lobbying was just disclosed - Quiver Quantitative
Putnam Investor News: If You Have Suffered Losses in Putnam Investment Management LLC, You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Cantor Fitzgerald reiterates Disc Medicine stock rating on pipeline catalysts - Investing.com
Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing - Moomoo
Disc Medicine CEO John Quisel sells $2.47m in shares By Investing.com - Investing.com Nigeria
Form 4 Disc Medicine Inc For: 14 July By Investing.com - Investing.com South Africa
Disc Medicine CEO John Quisel sells $2.47m in shares - Investing.com
Disc Medicine (NASDAQ: IRON) CEO exercises options and sells 33,000 shares - Stock Titan
Form 144 Disc Medicine For: 13 July By Investing.com - Investing.com South Africa
Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Price to earnings forward of Disc Medicine, Inc. – BOATS:IRON - TradingView
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com - Investing.com Nigeria
Form 4 Disc Medicine Inc For: 9 July By Investing.com - Investing.com Canada
Disc Medicine COO Jonathan Yu sells $8,250 in stock - Investing.com
Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan - Stock Titan
Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative - simplywall.st
Disc Medicine (IRON) H.C. Wainwright 27th Annual Global Investment Conference Summary - Quartr
Broker files Form 144 for 10,000 IRON shares (IRON) — option exercise sale - Stock Titan
IRON Q1 2026 Earnings: Narrower-than-expected loss highlights cost control amid clinical progressLong-Term Guidance - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Investors to Connect - The National Law Review
Disc Medicine (IRON) Could Be 67% Undervalued On Its $30 Million Loan Reset - Sahm
Did Disc Medicine’s Expanded Hercules Credit Access Just Shift IRON’s Funding Risk Profile? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Disc Medicine, Inc - The National Law Review
Disc Medicine’s chief legal officer sells $187,500 in stock - Investing.com UK
Disc Medicine COO Jonathan Yu sells $21,750 in company stock By Investing.com - Investing.com South Africa
Form 4 Disc Medicine Inc For: 30 June By Investing.com - Investing.com Nigeria
Disc Medicine’s chief legal officer sells $187,500 in stock By Investing.com - Investing.com Nigeria
Disc Medicine COO Jonathan Yu sells $21,750 in company stock - Investing.com
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
3.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):